Watch how SYLVANT® gets to work
03:37
Play the video to learn how SYLVANT® works to achieve a durable tumor and symptomatic response.
Home
THIS WEBSITE IS INTENDED FOR HEALTHCARE PROFESSIONALS (HCPs) ONLY
TRAINING & RESOURCES
We hope that you find the content useful to your clinical practice.
Diagnosis of iMCD
02:32
Dr. James Cavet
Consultant Haematologist, UK
In this video, Dr James Cavet discusses the symptoms of iMCD and the diagnostic pathway needed to make a correct diagnosis.
Treatment of iMCD
01:52
Dr. James Cavet
Consultant Haematologist, UK
In this video, Dr James Cavet discusses the treatment of iMCD using SYLVANT®.
Long term management of iMCD
01:58
Dr. James Cavet
Consultant Haematologist, UK
In this video, Dr James Cavet discusses long-term maintenance to reduce the risk of iMCD flares.
03:52
Watch Dr. David Fajgenbaum give his insight around the importance of identifying and treating patients early.
04:03
Dr. Fajgenbaum offers his full analysis on the retrospective claims analysis.
03:46
The author of the real world analysis Dr. Mukherjee gives his analysis of the results of the landmark study.
© 2021 EUSA Pharma
Date of prep: November 2021 GL-SIL-2100108
This medicinal product is subject to additional monitoring.
Adverse events to medicinal products should be reported.
Reporting forms and information can be found at your local health authority website.
To report a potential adverse event with an EUSA product please send an email to safety@eusapharma.com.
This website is developed and funded by EUSA for healthcare professionals only.
This website will not collect any personal or private information.
© 2021 EUSA Pharma - Registered in England No. 9329429
Registered office: Breakspear Park, Breakspear Way, Hemel Hempstead, Hertfordshire, HP2 4TZ